Literature DB >> 15144337

Maternal and neonatal outcome of 93 consecutive triplet pregnancies with 71% vaginal delivery.

Séverine Alran1, Olivier Sibony, Dominique Luton, Séverine Touitou, Virginie Fourchotte, Olivia Féraud, Jean-François Oury, Philippe Blot.   

Abstract

BACKGROUND: The aim of this study was to investigate neonatal and maternal data in a large series of triplet pregnancies as a function of the decision regarding the route of delivery.
METHODS: A retrospective series of 93 triplet pregnancies managed and delivered between 1989 and 2001 in a single perinatal department was analyzed. Seventy-eight women with triplet gestations who underwent a trial of labor were compared with 15 women with triplet gestations who delivered their infants by elective cesarean delivery. Neonatal outcomes assessed included respiratory distress syndrome, retinopathy of prematurity, necrotizing enterocolitis, intraventricular hemorrhage and Apgar scores. Maternal outcomes assessed included preeclampsia, blood transfusion, endometritis and urinary tract infection.
RESULTS: Sixty-six of 78 women (84%) who underwent a trial of labor had a successful vaginal delivery of all three neonates. The other 12 delivered their infants by cesarean delivery. Perinatal mortality referred to 104 triplet pregnancies was 48/1000.
CONCLUSIONS: Our experience suggests that offering vaginal delivery is an acceptable management plan for triplet gestation in a center with a sufficient number of triplet deliveries.

Entities:  

Mesh:

Year:  2004        PMID: 15144337     DOI: 10.1111/j.0001-6349.2004.00516.x

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  2 in total

1.  Maternal and neonatal outcomes in triplet gestations by trial of labor versus planned cesarean delivery.

Authors:  Danielle Peress; Annie Dude; Alan Peaceman; Lynn M Yee
Journal:  J Matern Fetal Neonatal Med       Date:  2018-01-07

Review 2.  17-Hydroxyprogesterone caproate in triplet pregnancy: an individual patient data meta-analysis.

Authors:  C A Combs; E Schuit; S N Caritis; A C Lim; T J Garite; K Maurel; D Rouse; E Thom; A T Tita; Bwj Mol
Journal:  BJOG       Date:  2015-12-10       Impact factor: 6.531

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.